Arcellx, Inc. (ACLX)
70.84
-3.24
(-4.37%)
USD |
NASDAQ |
Dec 09, 16:00
70.91
+0.07
(+0.10%)
After-Hours: 20:00
Arcellx Total Assets (Quarterly): 655.92M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 58.53B |
| Geron Corp. | 567.38M |
| Daré Bioscience, Inc. | 30.75M |
| Cartesian Therapeutics, Inc. | 372.68M |
| Cabaletta Bio, Inc. | 189.76M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 215.14M |
| Shareholders Equity (Quarterly) | 440.78M |
| Debt to Equity Ratio | 0.1175 |
| Current Ratio | 3.987 |
| Net Debt Paydown Yield | 0.09% |